Biotech · Private company · Philadelphia, PA, US
Carisma Therapeutics Inc.
SEC CIK 0001485003
Track this companyFree. Adds Carisma Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- CT-0508Phase 1 · HER2-positiveClinicalTrials.gov · fetched Nov 12, 2026
- CT-0525Phase 1 · HER2-positiveClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · HER2-positiveClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- CAR-monocytes for the Treatment of HER2 Overexpressing Solid TumorsPHASE1 · UNKNOWN · started Jan 8, 2024ClinicalTrials.gov NCT06254807 · fetched Nov 12, 2026
- CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsPHASE1 · UNKNOWN · started Feb 2, 2021ClinicalTrials.gov NCT04660929 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Dec 5, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 15, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 9, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 18, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 29, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 8, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 7, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 15, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 23, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 12, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 13, 2025 · fetched Nov 12, 2026